ETF Managers Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$355K Sell
432
-3,449
-89% -$2.6M 0.01% 519
2022
Q4
$2.8M Buy
3,881
+3,587
+1,220% +$2.65M 0.13% 93
2022
Q3
$203K Buy
294
+7
+2% +$4.41K 0.01% 596
2022
Q2
$172K Sell
287
-98
-25% -$63.7K 0.01% 660
2022
Q1
$267K Sell
385
-214
-36% -$135K 0.01% 558
2021
Q4
$385K Sell
599
-145
-19% -$89.2K 0.01% 564
2021
Q3
$451K Buy
744
+32
+4% +$19.9K 0.01% 547
2021
Q2
$389K Sell
712
-94
-12% -$47.6K 0.01% 564
2021
Q1
$379K Buy
806
+54
+7% +$26.3K 0.01% 552
2020
Q4
$360K Buy
752
+121
+19% +$65.3K 0.01% 499
2020
Q3
$362K Buy
631
+406
+180% +$246K 0.01% 383
2020
Q2
$137K Buy
+225
New +$128K ﹤0.01% 572
2016
Q1
$26K Buy
+66
New +$27.2K 0.02% 409

Other funds holding REGN